Education
About Us
Working with TipRanks
Follow Us
Emcure Pharmaceuticals Limited (IN:EMCURE)
:EMCURE
Summary of all the Indicators
Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Emcure Pharmaceuticals Limited’s (EMCURE) Moving Averages Convergence Divergence (MACD) indicator is 33.42, suggesting Emcure Pharmaceuticals Limited is a Sell.
Emcure Pharmaceuticals Limited’s (EMCURE) 20-Day exponential moving average is 1438.86, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹1,467.2, making it a Buy.
Emcure Pharmaceuticals Limited’s (EMCURE) 50-Day exponential moving average is 1375.82, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹1,467.2, making it a Buy.
Emcure Pharmaceuticals Limited (EMCURE) Pivot Points
Classic
1,445.82
1,461.68
1,476.82
1,492.68
1,507.82
1,523.68
1,538.82
Fibonacci
1,461.68
1,473.53
1,480.84
1,492.68
1,504.53
1,511.84
1,523.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Emcure Pharmaceuticals Limited (EMCURE) Moving Averages
MA5
1,485.02Sell
1,476.63Sell
MA10
1,465.97Buy
1,464.10Buy
MA20
1,434.09Buy
1,438.86Buy
MA50
1,370.12Buy
1,375.82Buy
MA100
1,252.62Buy
1,310.66Buy
MA200
1,243.67Buy
1,303.35Buy
Emcure Pharmaceuticals Limited’s (EMCURE) 10-Day exponential moving average is 1464.10, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹1,467.2, making it a Buy.
Emcure Pharmaceuticals Limited’s (EMCURE) 100-Day exponential moving average is 1310.66, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹1,467.2, making it a Buy.
Emcure Pharmaceuticals Limited’s (EMCURE) stock price is ₹1,467.2 and Emcure Pharmaceuticals Limited’s (EMCURE) 50-day simple moving average is 1370.12, creating a Buy signal.
Emcure Pharmaceuticals Limited’s (EMCURE) stock price is ₹1,467.2 and Emcure Pharmaceuticals Limited’s (EMCURE) 100-day simple moving average is 1252.62, creating a Buy signal.
Emcure Pharmaceuticals Limited’s (EMCURE) stock price is ₹1,467.2 and Emcure Pharmaceuticals Limited’s (EMCURE) 200-day simple moving average is 1243.67, creating a Buy signal.
Emcure Pharmaceuticals Limited (EMCURE) Technical Indicators
RSI (14)
58.69
Neutral
STOCH (9,6)
72.54
Neutral
STOCHRSI (14)
80.28
Sell
MACD (12,26)
33.42
Sell
ADX (14)
16.30
Buy
Williams %R
-28.05
Buy
CCI (14)
71.05
Neutral
ATR (14)
52.05
-
Ultimate Oscillator
49.90
Neutral
ROC
2.49
Buy
Emcure Pharmaceuticals Limited’s (EMCURE) Relative Strength Index (RSI) is 58.69, creating a Neutral signal.
Emcure Pharmaceuticals Limited’s (EMCURE) Trend Strength Indicator (ADX) is 16.30, creating a Buy signal.
Emcure Pharmaceuticals Limited’s (EMCURE) Commodity Channel Index (CCI) is 71.05, creating a Neutral signal.
Emcure Pharmaceuticals Limited’s (EMCURE) Price Rate of Change (ROC) is 2.49, creating a Buy signal.
FAQ
Is EMCURE a Buy, Hold, or Sell?
Based on EMCURE’s technical indicators, EMCURE is a Buy.
What is EMCURE’s RSI (14)?
EMCURE’s RSI (14) is 58.69, which suggests EMCURE is a Neutral.
What is EMCURE’s MACD?
EMCURE’s MACD is 33.42, which suggests EMCURE is a Sell.
What is EMCURE’s 5-day moving average?
EMCURE’s 5-day moving average is 1485.02, which suggests EMCURE is a Sell.
What is EMCURE’s 20-day moving average?
EMCURE 20-day moving average is 1434.09, which suggests EMCURE is a Buy.
What is EMCURE’s 50-day moving average?
EMCURE’s 50-day moving average is 1370.12, which suggests EMCURE is a Buy.
What is EMCURE’s 200-day moving average?
EMCURE’s 200-day moving average is 1243.67, which suggests EMCURE is a Buy.
What is EMCURE’s Williams % R (14)?
EMCURE’s Williams % R (14) is -28.05, which suggests EMCURE is a Buy.
What is EMCURE’s CCI (14)?
EMCURE’s CCI (14) is 71.05, which suggests EMCURE is a Neutral.
What is the share price of Emcure Pharmaceuticals Limited?